Iranian High Risk Regions due to Esophageal Cancer: Spatial Analysis of Cancer Registry Data
Gastroenterology and Hepatology from Bed to Bench,
Vol. 11 No. Supplement 1 (2018),
11 December 2018
,
Page s25-s31
https://doi.org/10.22037/ghfbb.v0i0.1530
Abstract
Aim: The aim of this study was to identify the esophageal cancer (EC) high risk regions to evaluate changes of relative risks (RRs) for both genders by time in Iranian provinces.
Background: EC is one of the public health problems in Iran. In spite of this fact, there is not comprehensive study estimating RRs across the Iranian provinces.
Methods: In this cross-sectional study the data for EC cases were extracted from Ministry of Health and Medical Education (MOHME) including 30 provinces from 2004 to 2010. For estimating the model parameters, we used Bayesian approach by regarding spatial correlations of adjacent provinces.
Results: The Northern half of Iran has high risk and other half has low risk. During the time, the range of RRs has decreased for both gender and also the dispersion of EC is decreasing for women but nearly is fixed for men.
Conclusion: While RR has declined during the study, focusing on the Northern half of Iran as high risk regions is a considerable fact for policymakers.
Keywords: Esophageal cancer, Relative risks, Bayesian model, Iran
(Please cite as: Najafimehr H, Ashtari S, Pourhoseingholi MA, Busani L. Iranian high risk regions due to esophageal cancer; spatial analysis of cancer registry data. Gastroenterol Hepatol Bed Bench 2018;11(Suppl. 1):S25-S31).
- Esophageal cancer
- Relative risks
- Bayesian model
- Iran
How to Cite
References
Sadjadi A, Nouraie M, Mohagheghi M, Mousavi-Jarrahi A, Malekezadeh R, Parkin D. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev 2005;6:359.
Kolahdoozan S, Sadjadi A, Radmard A, Khademi H. Five common cancers in Iran. Arch Iran Med 2010;13:143e6.
Pourhoseingholi MA, Fazeli Z, Moghimi-Dehkordi B, Vahedi M, Pourhoseingholi A, Safaee A, et al. Increased oesophageal cancer mortality rate in Iran. Arab Journal of Gastroenterology 2012;13:82-4.
Pourhoseingholi MA, Fazeli Z, Ashtari S, Bavand-Pour FSF. Mortality trends of gastrointestinal cancers in Iranian population. Gastroenterol Hepatol Bed Bench 2013;6:S52.
Wu K-S, Huo X, Zhu G-H. Relationships between esophageal cancer and spatial environment factors by using Geographic Information System. Science of the total environment 2008;393:219-25.
Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: Results of a population‐based Cancer Registry from Iran. Int J Cancer 2003;107:113-8.
Tzala E, Best N. Bayesian latent variable modelling of multivariate spatio-temporal variation in cancer mortality. Stat Methods Med Res 2008;17:97-118.
Kmet J, Mahboubi E. Esophageal cancer in the Caspian littoral of Iran: initial studies. Science 1972;175:846-53.
Nazemalhosseini Mojarad E, Farahani RK, Haghighi MM, Aghdaei HA, Kuppen PJ, Zali MR. Clinical implications of BRAF mutation test in colorectal cancer. Gastroenterol Hepatol Bed Bench. 2013;6:6-13.
Chamanpara P, Moghimbeigi A, Faradmal J, Poorolajal J. Joint disease mapping of two digestive cancers in Golestan Province, Iran using a shared component model. Osong Public Health Res Perspect 2015;6:205-10.
Marzoni A-SH, Moghimbeigi A, Faradmal J. Gastric and Esophageal Cancers Incidence Mapping in Golestan Province, Iran: Using BayesianeGibbs Sampling. Osong Public Health Res Perspect 2015;6:100-5.
Ahari SS, Agdam FB, Amani F, Yazdanbod A, Akhghari L. Analysis of the relationships between esophageal cancer cases and climatic factors using a Geographic Information System (GIS): a case study of Ardabil province in Iran. Asian Pac J Cancer Prev 2013;14:2071-7.
Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Annals of oncology 2008;20:556-63.
Etemadi A, Sadjadi A, Semnani S, Nouraie SM, Khademi H, Bahadori M. Cancer registry in Iran: a brief overview. Arch Iran Med 2008;11:577-80.
Ji J, Sundquist K, Sundquist J, Hemminki K. Comparability of cancer identification among death registry, cancer registry and hospital discharge registry. Int J Cancer 2012;131:2085-93.
Baghestani AR, Daneshva T, Pourhoseingholi MA, Asadzadeh H. Survival of Colorectal Cancer in the Presence of Competing- Risks - Modeling by Weibull Distribution. Asian Pac J Cancer Prev. 2016;17:1193-6.
Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Geneva: WHO2001;9:10.
Besag J, Newell J. The detection of clusters in rare diseases. Journal of the Royal Statistical Society Series A (Statistics in Society) 1991:143-55.
Zayeri F, Kavousi A, Najafimehr H. Spatial analysis of Relative Risks for skin cancer morbidity and mortality in Iran, 2008-2010. Asian Pac J Cancer Prev 2015;16:5225-31.
Pourhoseingholi MA, Vahedi M, Baghestani AR. Burden of gastrointestinal cancer in Asia; an overview. Gastroenterol Hepatol Bed Bench 2015;8:19.
Larki P, Gharib E, Yaghoob Taleghani M, Khorshidi F, Nazemalhosseini-Mojarad E, Asadzadeh Aghdaei H. Coexistence of KRAS and BRAF Mutations in Colorectal Cancer: A Case Report Supporting The Concept of Tumoral Heterogeneity. Cell J. 2017;19:113-117.
Almasi Z, Mohammadian-Hafshejani A, Salehiniya H. Incidence, mortality, and epidemiological aspects of cancers in Iran; differences with the world data. Journal of BU ON 2016;21:994-1004.
Rafiemanesh H, Rajaei-Behbahani N, Khani Y, Hosseini S, pournamdar Z, Mohammadian-Hafshejani A, et al. Incidence Trend and Epidemiology of Common Cancers in the Center of Iran. Glob J Health Sci 2016;8:146-55.
Mohammadi G, Akbari M, Mehrabi Y, Motlagh AG, Heidari M, Ghanbari S. Analysis of Cancer Incidence and Mortality in Iran Using Joinpoint Regression Analysis. Iran Red Crescent Med J 2017;19:e42071.
Somi MH, Mirinezhad K, Farhang S, Jazayeri E, Sani A, Seif-Farshad M, et al. Gastrointestinal cancer occurrence in East Azarbaijan: a five year study from North Western Iran. Asian Pac J Cancer Prev 2006;7:309.
Esmaeilzadeh N, Salahi-Moghaddam A, Khoshde A. Geographic distribution of important cancers in Iran. Hormozgan Medical Journal 2015;19:66-76.
Kamangar F, Malekzadeh R, Dawsey S, Saidi F. Esophageal Cancer in Northeastern Iran: A Review Arch Iranian Med 2007;10:70-82.
Eesteghamati A, Gouya M, Keshtkar A, Najafi L, Zali MR, Sanaei M, et al. Sentinel hospital-based surveillance of rotavirus diarrhea in iran. J Infect Dis. 2009;200:S244-47.
SadeghiehAhari S, BabaeiAgdam F, Amani F, Yazdanbod A, Akhghari L. Analysis of the Relationships between Esophageal Cancer Cases and Climatic Factors Using a Geographic Information System (GIS): a Case Study of Ardabil province in Iran. Asian Pacific J Cancer Prev 2013;14:2071-7.
Kavousi A, Meshkani MR, Mohammadzadeh M. Spatial analysis of relative risk of lip cancer in Iran: a Bayesian approach. Environmetrics: The official journal of the International Environmetrics Society 2009;20:347-59.
Parkin D, Läärä E, Muir C. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988;41:184-97.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
Pourhoseingholi MA, Faghihzadeh S, Hajizadeh E, Abadi A, Zali MR. Bayesian estimation of colorectal cancer mortality in the presence of misclassification in Iran. Asian Pac J Cancer Prev 2009;10:691-4.
Pourhoseingholi MA, Baghestani A, Abadi A, Hajizadeh N. Iranian regional cancer incidence is misclassified in neighborhood’s provinces. Gastroenterol hepatol Bed Bench 2016;9:75.
Hajizadeh N, Baghestani AR, Pourhoseingholi MA, Najafimehr H, Fazeli Z, Bosani L. Bayesian correction model for over-estimation and under-estimation of liver cancer incidence in Iranian neighboring provinces. Gastroenterol Hepatol Bed Bench 2017;10:S54.
- Abstract Viewed: 96 times
- PDF Downloaded: 108 times